September, 2002 – Marc D. Keats has been named President of Taiko Healthcare, Inc., a division of Taiko Pharmaceutical Co., Ltd., effective May, 2002. He will be responsible for overseeing all Taiko Healthcare operations in the U.S. and Japan, including both the natural health retail and e-commerce markets for the sale of the Tenshin Essentials product line in the U.S. An employee of the parent company since 1998, the most recent position Keats held was Manager of Taiko Pharmaceutical where he was responsible for the registration of Taiko’s supplements in overseas markets, and co-supervision of Phase II studies for Seirogan in the U.S. Prior to that, his management responsibilities included the development of new markets for animal healthcare products in Japan, as well as the development of a cosmetic ingredients market and establishment of several strategic ventures between Canadian and U.S. suppliers and Japanese manufacturers.
The Tenshin Essentials line includes Seirogan, for gentle, effective relief from mild diarrhea, Nattokin, to help maintain healthy digestion, and Elastase, a cholesterol-reducing enzyme to help maintain optimal heart health. The Tenshin Essentials line is distributed by Taiko Healthcare and manufactured by Taiko Pharmaceuticals. Taiko Healthcare’s customers benefit from the resources provided by the company’s pharmaceutical background. Full research facilities conduct research on raw materials and the Quality Control and Quality Assurance divisions guarantee that all final products meet Taiko’s strict standards for Good Manufacturing Practices (GMPs).